ANALYSIS OF THE LEGAL AND INSTITUTIONAL FRAMEWORK FOR MEDICAL DEVICES IN UEMOA COUNTRIES

Authors

  • Assitan dite Pendourou KALOGA Laboratoire du Développement du Médicament (LADME), Centre de Formation, de Recherche et d’Expertises en sciences du Médicament (CEA-CFOREM), École doctorale Sciences et Santé (ED2S), Université Joseph KI-ZERBO 03 BP 7021 Ouagadougou 03, Burkina Faso, Département d’Enseignement et de Recherche (DER) des Sciences Pharmaceutiques - Faculté de Pharmacie - Université des Sciences, des Techniques et des technologies de Bamako (USTTB), Mali et Direction de la pharmacie et du médicament, Ministère de la Santé, sise à Darsalam, Bamako Mali BP E 5202
  • Aboubacar SANGHO Département d’Enseignement et de Recherche (DER) des Sciences Pharmaceutiques - Faculté de Pharmacie - Université des Sciences, des Techniques et des technologies de Bamako (USTTB), Mali et Direction de la pharmacie et du médicament, Ministère de la Santé, sise à Darsalam, Bamako Mali BP E 5202 https://orcid.org/0000-0002-9459-2048
  • Hermine ZIME DIAWARA Laboratoire du Développement du Médicament (LADME), Centre de Formation, de Recherche et d’Expertises en sciences du Médicament (CEA-CFOREM), École doctorale Sciences et Santé (ED2S), Université Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso
  • Rokia SANOGO Département d’Enseignement et de Recherche (DER) des Sciences Pharmaceutiques - Faculté de Pharmacie - Université des Sciences, des Techniques et des technologies de Bamako (USTTB), Mali
  • Rasmané SEMDE Laboratoire du Développement du Médicament (LADME), Centre de Formation, de Recherche et d’Expertises en sciences du Médicament (CEA-CFOREM), École doctorale Sciences et Santé (ED2S), Université Joseph KI-ZERBO, 03 BP 7021 Ouagadougou 03, Burkina Faso

DOI:

https://doi.org/10.57220/jatpb.v4i1.215

Keywords:

Medical devices, Regulation, Marketing authorization, Market surveillance

Abstract

ABSTRACT

Introduction: Medical devices (MDs), like drugs, must be regulated to ensure their effectiveness and safety. The objective of this study is to analyze existing data on MD regulation in WAEMU countries.

Methodology: This was a cross-sectional descriptive study that took place in the eight WAEMU countries from December 2023 to July 2024. Data collection was carried out on the websites of the national pharmaceutical regulatory agencies/directorates and confirmed by these structures. Then, a data analysis was carried out according to the information found in the literature and in accordance with the Decision on the harmonization of the regulation of MDs in the WAEMU member states.

Results: The texts identified in the eight countries are laws, decrees, orders, decisions, circular notes, information notes and modalities. The analysis shows that five of the eight countries have adopted the definition adopted by the WAEMU in 2022 and recommended by the WHO in 2019; three countries have provided for classification and labeling of MDs; five have requirements for Marketing Authorization. Seven countries have provided for quality control of MDs but only two have provided their import control. Deficiencies concerning the existence or completeness of regulatory texts were also noted.

Conclusion: Further efforts are needed to implement or complete effective regulations that take into account country realities.

Downloads

Download data is not yet available.

Published

2025-06-30

How to Cite

KALOGA, A. dite P., SANGHO, A., ZIME DIAWARA, H., SANOGO, R., & SEMDE, R. (2025). ANALYSIS OF THE LEGAL AND INSTITUTIONAL FRAMEWORK FOR MEDICAL DEVICES IN UEMOA COUNTRIES. Journal Africain De Technologie Pharmaceutique Et Biopharmacie, 4(1), 50–61. https://doi.org/10.57220/jatpb.v4i1.215

Most read articles by the same author(s)

1 2 3 4 5 > >>